Skip to main content
logo
Gin Hwa Biotech Incorporation (TPEX:7806)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
60.90
0.00 (0.00%)
At close: Sep 2, 2026

TPEX:7806 Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Revenue
535.88538.65435.08
Revenue Growth
-23.80%-
Gross Profit
143.22163.77138.19
Operating Income
64.7791.8584.11
Net Income
55.775.3366.75
Earnings Per Share
2.083.043.01
EPS Growth
-1.00%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Cash & Investments
74.71117.65116.51
Total Debt
160.73213.63181.43
Net Cash (Debt)
-86.01-95.98-64.92
Net Cash Growth
---
Net Cash Per Share
-3.21-3.87-2.93

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Operating Cash Flow
127.278.7970.51
Capital Expenditures
-315.25-313.45-111.19
Free Cash Flow
-188.05-234.66-40.68
Free Cash Flow Growth
---

Margins
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Gross Margin
26.73%30.40%31.76%
Operating Margin
12.09%17.05%19.33%
Pretax Margin
12.94%17.67%18.78%
Profit Margin
10.39%13.98%15.34%
FCF Margin
-35.09%-43.56%-9.35%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024
Period EndingSep '26 Dec '25 Dec '24
PE Ratio
28.8923.5326.63
PS Ratio
3.613.294.09